Anaesthetic management of bilateral hand transplantation
Sir, Vascularised composite tissue allotransplantation is now considered a feasible reconstructive option for patients with upper extremity loss. We are reporting the anaesthetic management of the first hand transplantation in India, world's first in a non-white.
A 31 year-old male patient who lost both his hands in a train accident was put on the waiting list of the transplant programme 2 years back. Donor became available when the family of a 24 year-old healthy male patient, diagnosed to be brain dead, came forward with the willingness to donate both his hands.
Pre-operatively, the recipient received tacrolimus, mycophenolate mofetil and valganciclovir orally. Under local anaesthesia, right sub-clavian central line, right dorsalis pedis arterial line and two 16 G peripheral lines in the feet were introduced. Thymoglobulin 1 mg/kg, methylprednisolone 500 mg and piperacillin/tazobactam 4.5 g were given intravenously.
The hand harvesting was performed under tourniquet and the limbs were perfused with cold HDK solution through the brachial vessels before amputation. Other organs were harvested only after the hand harvesting was done. The recipient received a standard anaesthesia protocol: induction with propofol, pancuronium for muscle relaxation, morphine as analgesic, maintenance with oxygen and nitrous oxide (1:2) with isoflurane (1%), and mechanical ventilation. Supra-clavicular brachial plexus catheters were placed bilaterally with the aid of an ultrasound probe and 10 ml bupivacaine 0.25% was given on each side. Intra-operatively, the patient received methylprednisolone 500 mg and bolus of intravenous fluid with 1 meq/kg sodium bicarbonate prior to reperfusion. The surgery took 17 h; in the last 4 h he went into severe hypotension requiring colloids (1.5 L) and 7 units of packed red blood cells (PRBC). Vasoconstrictors were avoided for fear of vasospasm at the anastomotic sites. The patient had received 12.5 L of Ringer lactate intra-operatively. At the end of the surgical procedure, bilateral supraclavicular block was repeated with 10 ml of 0.5% bupivacaine. The patient was ventilated for 3 h until he became normothermic.
The patient [ Figure 1 ] had an uneventful post-operative period and was shifted out of the transplant Intensive Care Unit after 2 weeks.
The Pittsburgh Upper Extremity Transplant Anesthesiology Protocol offers important guidelines and recommendations for management of upper extremity transplant recipients focusing on fluid management, intraoperative monitoring and regional anaesthesia strategies. [1] In addition, problems associated with massive blood loss, hypothermia and reperfusion injury should be taken care of.
The ideal time of limb procurement is prior to solid organ harvest, i.e., before the aorta is cross-clamped, given the concern for ischaemia time. [2] Use of tourniquet minimises blood loss in the heart-beating donor and reduces the risk of destabilisation due to blood loss. [3] The standard immunosuppression involves induction therapy with antibodies combined with multi-drug maintenance therapy.
Since these surgeries involve massive blood loss, [4] with an inherent risk of dilutional coagulopathy and rhabdomyolysis, [5] multiple large intravenous access is essential, so is arrangement of at least 10 units of PRBC and adequate products. The goals of haemodynamic management include avoidance of hypotension, reduction of vasopressor use and improving oxygenation to the graft. [1] During microsurgeries with multiple vessel anastomoses, improved oxygenation to graft is usually accomplished by haemodilution and controlled hypertension by means of volume expansion. Hence, aim is to have a well-filled patient with a good urine output. As viscous blood tends to clot around the anastomotic sites, haemoglobin of >10 g/dL is not recommended. In addition, regional anaesthesia provides vasodilatation which improves perfusion of the graft. Intra-operatively we supplemented general anaesthesia with brachial plexus block using 0.25% bupivacaine, mainly to obtain vasodilatation. However, post-operatively 0.5% bupivacaine was used aiming intense block that provided maximum vasodilatation with analgesia and motor block.
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Thoracic spinal cord stimulation for low back pain in a patient with permanent pacemaker
Sir, Spinal cord stimulation (SCS) for chronic pain management involves placement of epidural electrodes, which could theoretically evoke device-to-device interference in patients with a permanent cardiac pacemaker (PPM). [1] We report a case of a 52-year-old female patient with double-chamber Medronic Kappa KDR903 ® device with sensor accelerator-DDDR (Medtronic Inc., Minneapolis, MN, USA/compatible with bipolar diathermy) due to complete heart block, who underwent SCS implantation for treatment of severe chronic low back pain. Several oral analgesic regimens, non-invasive (hydro/physiotherapy) or minimal invasive (electro-acupuncture [EA]) treatment methods had been tested previously unsuccessfully or with extremely short duration of pain relief (24-36 h pain-free period after EA). Therefore, after consultation with a cardiologist, due to patient's history, she was deemed to be a good candidate for SCS.
